XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity - USD ($)
Total
Noncontrolling Interest [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Dec. 31, 2020 $ 1,371,615,000   $ 0 $ 50,000 $ 1,501,206,000 $ (129,370,000) $ (271,000)
Balance Balance, Shares at Dec. 31, 2020     0 504,274,890      
Beginning Balance , Redeemable Non-Controlling Interest at Dec. 31, 2020   $ 14,179,000          
Issuance of common stock 1,007,000       1,007,000    
Issuance of common stock (Shares)       110,679      
Stock-based compensation expense 11,838,000       11,838,000    
Stock-based compensation expense, Shares       883,729      
Exercise of stock options—net of tax 444,000       444,000    
Exercise of stock options—net of tax , Shares       161,080      
Dividend to CCCIS stockholders (134,551,000)         (134,551,000)  
Foreign currency translation adjustment 7,000           7,000
Net income (loss) (5,084,000)         (5,084,000)  
Ending Balance , Redeemable Non-Controlling Interest at Mar. 31, 2021   14,179,000          
Ending Balance at Mar. 31, 2021 1,245,276,000   $ 0 $ 50,000 1,514,495,000 (269,005,000) (264,000)
Ending Balance, Shares at Mar. 31, 2021     0 505,430,378      
Beginning Balance at Dec. 31, 2020 1,371,615,000   $ 0 $ 50,000 1,501,206,000 (129,370,000) (271,000)
Balance Balance, Shares at Dec. 31, 2020     0 504,274,890      
Beginning Balance , Redeemable Non-Controlling Interest at Dec. 31, 2020   14,179,000          
Foreign currency translation adjustment (18,000)            
Net income (loss) (191,050,000)            
Ending Balance , Redeemable Non-Controlling Interest at Sep. 30, 2021   14,179,000          
Ending Balance at Sep. 30, 2021 1,837,038,000   $ 0 $ 60,000 2,525,750,000 (688,483,000) (289,000)
Ending Balance, Shares at Sep. 30, 2021     0 603,170,380      
Beginning Balance at Mar. 31, 2021 1,245,276,000   $ 0 $ 50,000 1,514,495,000 (269,005,000) (264,000)
Balance Balance, Shares at Mar. 31, 2021     0 505,430,378      
Beginning Balance , Redeemable Non-Controlling Interest at Mar. 31, 2021   14,179,000          
Stock-based compensation expense 2,579,000       2,579,000    
Foreign currency translation adjustment (36,000)           (36,000)
Net income (loss) 3,816,000         3,816,000  
Ending Balance , Redeemable Non-Controlling Interest at Jun. 30, 2021   14,179,000          
Ending Balance at Jun. 30, 2021 1,251,635,000   $ 0 $ 50,000 1,517,074,000 (265,189,000) (300,000)
Ending Balance, Shares at Jun. 30, 2021     0 505,430,378      
Stock-based compensation expense 213,966,000       213,966,000    
Net equity infusion from the Business Combination 704,841,000     $ 10,000 704,831,000    
Net equity infusion from the Business Combination (Shares)       97,740,002      
Dividend to CCCIS stockholders (134,627,000)         (134,627,000)  
Deemed distribution to CCCIS option holders (9,006,000)       (9,006,000)    
Company Vesting Shares granted to CCCIS stockholders         98,885,000 (98,885,000)  
Foreign currency translation adjustment 11,000           11,000
Net income (loss) (189,782,000)         (189,782,000)  
Ending Balance , Redeemable Non-Controlling Interest at Sep. 30, 2021   14,179,000          
Ending Balance at Sep. 30, 2021 1,837,038,000   $ 0 $ 60,000 2,525,750,000 (688,483,000) (289,000)
Ending Balance, Shares at Sep. 30, 2021     0 603,170,380      
Beginning Balance at Dec. 31, 2021 1,872,318,000   $ 0 $ 61,000 2,618,924,000 (746,352,000) (315,000)
Balance Balance, Shares at Dec. 31, 2021     0 609,768,296      
Beginning Balance , Redeemable Non-Controlling Interest at Dec. 31, 2021 14,179,000 14,179,000          
Stock-based compensation expense 23,644,000       23,644,000    
Exercise of stock options—net of tax 10,633,000       10,633,000    
Exercise of stock options—net of tax , Shares       3,961,270      
Exercise of Warrants-Net, Shares       1,246      
Issuance of common stock upon vesting of RSUs-net of tax, Shares       27,314      
Foreign currency translation adjustment 9,000           9,000
Net income (loss) 11,975,000         11,975,000  
Ending Balance , Redeemable Non-Controlling Interest at Mar. 31, 2022   14,179,000          
Ending Balance at Mar. 31, 2022 1,918,579,000     $ 61,000 2,653,201,000 (734,377,000) (306,000)
Ending Balance, Shares at Mar. 31, 2022       613,758,126      
Beginning Balance at Dec. 31, 2021 1,872,318,000   $ 0 $ 61,000 2,618,924,000 (746,352,000) (315,000)
Balance Balance, Shares at Dec. 31, 2021     0 609,768,296      
Beginning Balance , Redeemable Non-Controlling Interest at Dec. 31, 2021 14,179,000 14,179,000          
Foreign currency translation adjustment (804,000)            
Net income (loss) 37,334,000            
Ending Balance , Redeemable Non-Controlling Interest at Sep. 30, 2022 14,179,000 14,179,000          
Ending Balance at Sep. 30, 2022 2,010,620,000     $ 62,000 2,720,695,000 (709,018,000) (1,119,000)
Ending Balance, Shares at Sep. 30, 2022       620,117,025      
Beginning Balance at Mar. 31, 2022 1,918,579,000     $ 61,000 2,653,201,000 (734,377,000) (306,000)
Balance Balance, Shares at Mar. 31, 2022       613,758,126      
Beginning Balance , Redeemable Non-Controlling Interest at Mar. 31, 2022   14,179,000          
Stock-based compensation expense 28,403,000       28,403,000    
Exercise of stock options—net of tax 4,723,000     $ 1,000 4,722,000    
Exercise of stock options—net of tax , Shares       1,713,991      
Issuance of common stock upon vesting of RSUs-net of tax, Shares       29,834      
Foreign currency translation adjustment (303,000)           (303,000)
Net income (loss) 15,564,000         15,564,000  
Ending Balance , Redeemable Non-Controlling Interest at Jun. 30, 2022   14,179,000          
Ending Balance at Jun. 30, 2022 1,966,966,000     $ 62,000 2,686,326,000 (718,813,000) (609,000)
Ending Balance, Shares at Jun. 30, 2022       615,501,951      
Stock-based compensation expense 28,722,000       28,722,000    
Exercise of stock options—net of tax $ 7,455,000       7,455,000    
Exercise of stock options—net of tax , Shares 2,685,029            
Issuance of common stock under employee stock purchase plan, Value $ 3,197,000       3,197,000    
Issuance of common stock under employee stock purchase plan, Shares       408,879      
Issuance of common stock upon vesting of RSUs-net of tax (5,005)       (5,005)    
Issuance of common stock upon vesting of RSUs-net of tax, Shares       1,521,166      
Foreign currency translation adjustment (510,000)           (510,000)
Net income (loss) 9,795,000         9,795,000  
Ending Balance , Redeemable Non-Controlling Interest at Sep. 30, 2022 14,179,000 $ 14,179,000          
Ending Balance at Sep. 30, 2022 $ 2,010,620,000     $ 62,000 $ 2,720,695,000 $ (709,018,000) $ (1,119,000)
Ending Balance, Shares at Sep. 30, 2022       620,117,025